Opinion
Video
Author(s):
Amir H. Lebastchi, MD, explores the evolving landscape in the context of fusion-guided prostate biopsy methods.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
Study shows value of precision-based approaches in prostate cancer
Dr. Murphy on increasing diversity in cancer clinical trials
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
MRI and focal therapy may enable men on AS to safely delay surgery or radiation
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC
Urologic surgeons successfully complete world’s first bladder transplant